Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer

  • Authors:
    • Ying Chen
    • Qingqu Guo
    • Bo Zhang
    • Muxing Kang
    • Qiuping Xie
    • Yulian Wu
  • View Affiliations

  • Published online on: July 2, 2012     https://doi.org/10.3892/ol.2012.783
  • Pages: 792-798
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bufalin, an active component of the Chinese medicine chan'su, has been reported to have an inhibitory effect on the growth of various types of cancer cells. In the present study, we investigated whether gemcitabine combined with bufalin enhanced the antitumor efficacy in pancreatic cancer. Three pancreatic cancer cell lines (Bxpc-3, Mia PaCa-2 and Panc-1) were treated with gemcitabine and/or bufalin in vitro. The combination treatment demonstrated greater inhibition of cellular growth and apoptosis. The activity of apoptosis signal-regulating kinase 1 (ASK1)/JNK was upregulated in gemcitabine-induced apoptosis when combined with bufalin. We also observed that tumor growth was significantly inhibited by the combination therapy in a tumor-bearing mouse model, and upregulation of ASK1 activity was validated by immunohistochemical staining. These results suggest that bufalin may be a potential chemotherapeutic agent for pancreatic cancer, which could enhance the antitumor efficacy of gemcitabine when used in combination, possibly through the activation of ASK1/JNK.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 4 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Guo Q, Zhang B, Kang M, Xie Q and Wu Y: Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncol Lett 4: 792-798, 2012.
APA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., & Wu, Y. (2012). Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer. Oncology Letters, 4, 792-798. https://doi.org/10.3892/ol.2012.783
MLA
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4.4 (2012): 792-798.
Chicago
Chen, Y., Guo, Q., Zhang, B., Kang, M., Xie, Q., Wu, Y."Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer". Oncology Letters 4, no. 4 (2012): 792-798. https://doi.org/10.3892/ol.2012.783